Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.

Article Details

Citation

Copy to clipboard

Fu H, Rong J, Chen Z, Zhou J, Collier T, Liang SH

Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.

J Med Chem. 2022 Aug 25;65(16):10755-10808. doi: 10.1021/acs.jmedchem.2c00633. Epub 2022 Aug 8.

PubMed ID

35939391 [ View in PubMed

]

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) and 5-HT receptors (5-HTRs) have crucial roles in various neuropsychiatric disorders and neurodegenerative diseases, making them attractive diagnostic and therapeutic targets. Positron emission tomography (PET) is a noninvasive nuclear molecular imaging technique and is an essential tool in clinical diagnosis and drug discovery. In this context, numerous PET ligands have been developed for "visualizing" 5-HTRs in the brain and translated into human use to study disease mechanisms and/or support drug development. Herein, we present a comprehensive repertoire of 5-HTR PET ligands by focusing on their chemotypes and performance in PET imaging studies. Furthermore, this Perspective summarizes recent 5-HTR-focused drug discovery, including biased agonists and allosteric modulators, which would stimulate the development of more potent and subtype-selective 5-HTR PET ligands and thus further our understanding of 5-HTR biology.